LIMN
Liminatus Pharma, Inc. Class A Common Stock
stockNASDAQ
Market OpenOct 21, 2026 10:38:33 AM EDT
3.18USD+0.952%(+0.03)111,063
LIMN Financials
In Q2 FY 2026 (ended ), Liminatus Pharma, Inc. Class A Common Stock (LIMN) reported net income of −$1.41M, operating cash flow of −$970K, and assets of $3.4M.
Loading financial statements…